Please do not include detailed medical information in this form. Information you submit is handled according to our Privacy Policy and Notice of Privacy Practices.
Please do not include detailed medical information in this form. Information you submit is handled according to our Privacy Policy and Notice of Privacy Practices.
FDA-approved naltrexone (Vivitrol) blocks the rewarding effects of opioids and alcohol — eliminating the biochemical reinforcement that drives relapse. Non-addictive, no tapering required, effective for both opioid and alcohol use disorder. Integrated with therapy at Compass Recovery in Cypress, CA — close to San Clemente.
Available 24/7 for San Clemente residents — (949) 444-9047
Please do not include detailed medical information in this form. Information you submit is handled according to our Privacy Policy and Notice of Privacy Practices.
Recovery from opioid or alcohol addiction isn't simply a matter of willpower. For many people, the brain's reward system has been rewired to crave the substance, creating a powerful biochemical pull toward relapse. Naltrexone (Vivitrol) works differently than other medications by blocking opioid receptors in the brain, effectively shutting down the reward response that reinforces continued use. For San Clemente residents, access to this medication is especially important given the region's documented opioid crisis and the limited availability of medication-assisted treatment providers nearby.
Compass Recovery's Naltrexone program is conveniently located in nearby Cypress, CA and pairs this non-addictive medication with comprehensive counseling, group therapy, and dual diagnosis care. Unlike Suboxone, Naltrexone is an opioid antagonist rather than an agonist, meaning it carries no physical dependence risk, requires no tapering process, and won't create a new dependency. It's one of the few FDA-approved treatments effective for both opioid and alcohol use disorder, giving you a clear path forward without trading one problem for another.
Naltrexone is FDA-approved for opioid and alcohol use disorder. It is particularly well-suited for clients where several of these apply.
Naltrexone is available as a daily oral tablet (Revia) or a monthly extended-release injection (Vivitrol). Both block opioid and alcohol reward. Our clinical team determines which form is the right fit based on your history, lifestyle, and treatment goals.
A daily 50mg tablet that maintains a consistent opioid and alcohol block. Effective and lower cost, but depends on daily adherence — which can become a vulnerability during high-stress or high-craving periods.
A once-monthly intramuscular injection that provides continuous naltrexone coverage without daily pill decisions. Removes the daily adherence barrier — the most common reason oral naltrexone fails — and is particularly effective during the highest-risk relapse windows after discharge.
San Clemente has a significant professional community in healthcare, law enforcement, and legal fields where maintaining an unrestricted career path matters deeply. Naltrexone's non-controlled status makes it the clear choice for professionals who can't afford the complications that come with controlled medications. Compass Recovery understands these stakes. Our Naltrexone program in Cypress gives San Clemente professionals a straightforward path to recovery that doesn't compromise their licenses, clearances, or peace of mind.
Naltrexone is an opioid antagonist — it blocks receptors rather than activating them. No physical dependence, no withdrawal on discontinuation, no controlled substance classification. It cannot be misused.
One of the few FDA-approved medications effective for both opioid use disorder and alcohol use disorder. A single treatment option for clients with complex or dual substance histories.
Naltrexone is prescribed and monitored by our licensed clinical team. Both oral and Vivitrol injection forms are available, with dosing and form determined by your clinical profile.
Depression, anxiety, PTSD, and trauma frequently co-occur with opioid and alcohol use disorder. Our team treats both simultaneously — not as separate referrals at a later stage.
Our signature program helps every client identify their life purpose and build a future they genuinely want — giving recovery a compelling reason that medication and willpower alone cannot provide.
California DHCS licensed (No. 300331CP) and Joint Commission accredited. Our Naltrexone program meets the highest clinical and regulatory standards for behavioral health in California.
Our admissions team answers 24/7. We will assess your situation, verify your insurance, and arrange a clinical evaluation for Naltrexone or Vivitrol — close to San Clemente.
From your first call to your first dose or injection, here is exactly what happens when you reach out to Compass Recovery.
Call (949) 444-9047 any time. We review your substance use history, current health, and whether you have completed the opioid-free period required before Naltrexone induction.
We confirm your Aetna, Blue Shield, Cigna, TriWest, or other benefits at no cost. Both oral Naltrexone and Vivitrol injection are covered under most major plans.
A licensed prescriber confirms you are opioid-free, assesses liver function, and determines the right form (oral vs Vivitrol) and dosing schedule for your clinical situation.
First dose or Vivitrol injection at our Cypress facility, accessible from San Clemente. Therapy begins alongside medication from day one across all levels of care.
Naltrexone blocks opioids and alcohol at the brain level while our San Clemente team provides therapy that addresses what drives your use, and we're here whenever you're ready, without pressure or judgment.
Available 24 hours • 7 days a week • Cypress, Orange County, CA
Accredited/Certified by The Joint Commission.
Compass Recovery, Inc.
9431 & 9432 Alderbury St., Cypress, CA 90630
California DHCS License No. 300331CP, expires 11/30/2027
Joint Commission HCO ID 603196
Compass Recovery protects patient information in accordance with HIPAA, 42 CFR Part 2, and California law. View our Notice of Privacy Practices.